47.572839, 7.579452
Sandoz
Basel, Switzerland
- Verified lead
- Richard Saynor
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Generics, Biosimilars, and Global Essential-Medicines Supply
- Review cycle
- May 2026
- Full address
- Lichtstrasse 35, CH-4056 Basel, Switzerland
- Site coordinates
- 47.572839, 7.579452
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Sandoz corporate-governance page confirming Richard Saynor as CEO.
- Editorial note
- Basel headquarters node coordinating generics and biosimilars governance across the wider European manufacturing network.
Generics, Biosimilars, and Global Essential-Medicines Supply
GMP medicines manufacturing, Global generics and biosimilars quality systems
Basel headquarters node coordinating generics and biosimilars governance across the wider European manufacturing network.
Sandoz
Generics, Biosimilars, and Global Essential-Medicines Supply · Global regulated medicines supply
Basel headquarters node coordinating generics and biosimilars governance across the wider European manufacturing network.
- Lead
- Richard Saynor (verified ↗)
- Address
- Lichtstrasse 35, CH-4056 Basel, Switzerland (source ↗)
- Compliance
- GMP medicines manufacturing
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global regulated medicines supply
- Capabilities
- Generics Manufacturing · Biosimilars Supply · Commercial Medicines Operations
- Founded
- 1886
- Headcount
- 10000+
- Company page (open ↗)
Richard Saynor
Chief Executive Officer
Official Sandoz corporate contact page listing Lichtstrasse 35, Basel.
Open sourceGlobal regulated medicines supply
Basel, Switzerland. Generics, Biosimilars, and Global Essential-Medicines Supply. Review completed on 14 Mar 2026.
Swiss, EMA, FDA, and global medicines oversight
GMP medicines manufacturing, Global generics and biosimilars quality systems
Generics, Biosimilars, and Global Essential-Medicines Supply
Basel headquarters node coordinating generics and biosimilars governance across the wider European manufacturing network.
Sandoz broadens the Swiss cluster layer with a current executive record and a public business surface centered on generics and biosimilars.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Sandoz located?
- Sandoz operates from Lichtstrasse 35, CH-4056 Basel, Switzerland, Basel, Switzerland.
- Who runs Sandoz?
- Sandoz is led by Richard Saynor, Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does Sandoz hold?
- Sandoz is documented under GMP medicines manufacturing.
- What does Sandoz do?
- Basel headquarters node coordinating generics and biosimilars governance across the wider European manufacturing network. Core capabilities: Generics Manufacturing, Biosimilars Supply, Commercial Medicines Operations.
Related technical briefs
Briefs that name Basel as a covered market or city.
